Evidence map›Paper›PMID 31109109›Full record

ArticleJournal of clinical medicine2019

Circulating Soluble CD36 is Similar in Type 1 and Type 2 Diabetes Mellitus versus Non-Diabetic Subjects.

Esmeralda Castelblanco, Lucía Sanjurjo, Mireia Falguera, Marta Hernández, José-Manuel Fernandez-Real, Maria-Rosa Sarrias, Nuria Alonso, Didac Mauricio

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. CD36 and Its Role in Obesity.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2026
    Review
  2. Implications ofAntioxidants (Basel, Switzerland) · 2025
    Article
  3. Observational
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 1 country.

Esmeralda CastelblancoDepartment of Endocrinology & Nutrition, University, Hospital de la Santa Creu i Sant Pau & Institut d'Investigació Biomèdica Sant Pau (IIB Sant Pau), 08041 Barcelona, Spain. esmeraldacas@gmail.com.
Lucía SanjurjoInnate Immunity Group, Health Sciences Research Institute Germans Trias i Pujol, 08916 Badalona, Spain. lsanjurjo@igtp.cat.
Mireia FalgueraPrimary Health Care Cervera, Gerència d'Atenció Primaria, Institut Català de la Salut, Unitat de Suport a la Recerca, Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), 25200 Cervera, Spain. didacmauricio@gmail.com.
Marta HernándezDepartment of Endocrinology & Nutrition, University Hospital Arnau de Vilanova & Biomedical Research Institute of Lleida (IRBLleida), 25198 Lleida, Spain. mrsarrias@igtp.cat.
José-Manuel Fernandez-RealDepartment of Diabetes, Endocrinology & Nutrition, Hospital Dr Josep Trueta & Biomedical Research Institute of Girona (IDIBGI), 17007 Girona, Spain. mireiafalguera@hotmail.com.
Maria-Rosa SarriasInnate Immunity Group, Health Sciences Research Institute Germans Trias i Pujol, 08916 Badalona, Spain. martahernandezg@gmail.com.
Nuria AlonsoCentre for Biomedical Research on Diabetes and Associated Metabolic Diseases (CIBERDEM), 08907 Barcelona, Spain. nalonso32416@yahoo.es.
Didac MauricioDepartment of Endocrinology & Nutrition, University, Hospital de la Santa Creu i Sant Pau & Institut d'Investigació Biomèdica Sant Pau (IIB Sant Pau), 08041 Barcelona, Spain. didacmauricio@gmail.com.
Universitat de Lleida · ESCentre for Biomedical Network Research on Rare Diseases · ESCentro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas · ESHospital de Sant Pau · ESHospital Universitari Arnau de Vilanova · ESInstitut d'Investigació Biomèdica de Girona · ESInstitut d'Investigació en Ciències de la Salut Germans Trias i Pujol · ES

Funding

European Foundation for the Study of Diabetes 2014-EFSD-00914
6 · The paper itself

Abstract

The aim of this study was to determine whether plasma concentrations of sCD36 (soluble CD36) are associated with the presence of type 1 or type 2 diabetes. Plasma levels of sCD36 were analysed in 1023 subjects (225 type 1 diabetes (T1D) patients, 276 type 2 diabetes (T2D) patients, and 522 non-diabetic control subjects) using an enzyme-linked immunosorbent assay (ELISA). Multinomial and logistic regression models were performed to evaluate associations with sCD36 and its association with diabetes types. There were no significant differences in sCD36 (

Indexed as

sCD36type 1 diabetes mellitustype 2 diabetes mellitus

Identifiers

PMID31109109
PMCPMC6571689
OpenAlexW2946010818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.